Top Markets
#1 MowCat MowCat +48.95%
#2 Bermuda Shorts Bermuda Shorts +25.87%
#3 Velvet Velvet +24.42%
#4 Audiera Audiera +22.52%
#5 aPriori aPriori +20.79%
#6 Derive Derive +20.37%
#7 Biconomy Biconomy +18.03%
#8 Quack AI Quack AI +17.31%
#9 Geodnet Geodnet +11.94%
#10 Palladium Network Palladium Network +10.99%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
IMV Inc. IMV Inc.

IMV Inc.

IMV
Classifica tra le azioni #35289
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Prezzo delle azioni
$0.82959892
Ultima sincronizzazione: 2023-05-23
Capitalizzazione di mercato
$4.16M
Variazione (1 giorno)
-0.04%
Variazione (1 anno)
0.00%
Paese
CA
Scambia IMV Inc. (IMV)

Categoria

Healthcare
Storico del prezzo dell'azione per IMV Inc. (IMV)
Prezzo di chiusura più alto: $0.83 il 2023-05-01

Prezzo di chiusura più basso: $10.12 il 2012-08-01
Storico del prezzo dell'azione di IMV Inc. dal 2012 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -68.78%
2022 -80.40%
2021 -58.02%
2020 14.41%
2019 -48.63%
2018 2.19%
2017 210.21%
2016 -3.76%
2015 -10.27%
2014 42.27%
2013 23.64%
2012 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE